Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (111-120 of 225) with videos related to

Pageof 23
Sort By:
Rheumatology Advances in Practice|December 10, 2021
Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patientsTheresa Burkard, Ross D Williams, Enriqueta Vallejo-Yagüe, et al.
Frontiers in Immunology|May 26, 2023
Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseasesCeline Lamacchia, Denis Mongin, Catherine Juillard, et al.
Rheumatology (Oxford, England)|August 27, 2024
Antibiotics in inflammatory arthritis and background population one year before and after diagnosis: a nationwide drug utilization studyMaja S Kragsnaes, Nickolaj Risbo, Jens Kristian Pedersen, et al.
RMD Open|January 31, 2024
Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritisBenoît Thomas P Gilbert, Raul Yhossef Tito Tadeo, Celine Lamacchia, et al.
Arthritis and Rheumatism|May 1, 2007
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agentsAxel Finckh, Adrian Ciurea, Laure Brulhart, et al.
Open Access Rheumatology : Research and Reviews|June 17, 2024
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment RetentionJanet Pope, Axel Finckh, Lucia Silva-Fernández, et al.
Arthritis Care & Research|October 6, 2011
Pain as an important predictor of psychosocial health in patients with rheumatoid arthritisDelphine S Courvoisier, Thomas Agoritsas, Jérôme Glauser, et al.
Annals of the Rheumatic Diseases|July 10, 2025
When borders impact science: what is the future of European rheumatology research?Frank Verhoeven, Athan Baillet, Celine Demougeot, et al.
Frontiers in Cellular and Infection Microbiology|February 6, 2023
Characterization of serum biomarkers and antibody responses against <i>Prevotella</i> spp. in preclinical and new-onset phase of rheumatic diseasesLena Amend, Benoît Thomas P Gilbert, Penelope Pelczar, et al.
Rheumatology (Oxford, England)|August 24, 2016
Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritisErnest Choy, Daniel Aletaha, Frank Behrens, et al.
Pageof 23

Showing results (111-120 of 225) with videos related to

Sort By:
Pageof 23
Rheumatology Advances in Practice|December 10, 2021
Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patientsTheresa Burkard, Ross D Williams, Enriqueta Vallejo-Yagüe, et al.
Frontiers in Immunology|May 26, 2023
Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseasesCeline Lamacchia, Denis Mongin, Catherine Juillard, et al.
Rheumatology (Oxford, England)|August 27, 2024
Antibiotics in inflammatory arthritis and background population one year before and after diagnosis: a nationwide drug utilization studyMaja S Kragsnaes, Nickolaj Risbo, Jens Kristian Pedersen, et al.
RMD Open|January 31, 2024
Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritisBenoît Thomas P Gilbert, Raul Yhossef Tito Tadeo, Celine Lamacchia, et al.
Arthritis and Rheumatism|May 1, 2007
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agentsAxel Finckh, Adrian Ciurea, Laure Brulhart, et al.
Open Access Rheumatology : Research and Reviews|June 17, 2024
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment RetentionJanet Pope, Axel Finckh, Lucia Silva-Fernández, et al.
Arthritis Care & Research|October 6, 2011
Pain as an important predictor of psychosocial health in patients with rheumatoid arthritisDelphine S Courvoisier, Thomas Agoritsas, Jérôme Glauser, et al.
Annals of the Rheumatic Diseases|July 10, 2025
When borders impact science: what is the future of European rheumatology research?Frank Verhoeven, Athan Baillet, Celine Demougeot, et al.
Frontiers in Cellular and Infection Microbiology|February 6, 2023
Characterization of serum biomarkers and antibody responses against <i>Prevotella</i> spp. in preclinical and new-onset phase of rheumatic diseasesLena Amend, Benoît Thomas P Gilbert, Penelope Pelczar, et al.
Rheumatology (Oxford, England)|August 24, 2016
Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritisErnest Choy, Daniel Aletaha, Frank Behrens, et al.
Pageof 23